Skip to main content
Top
Published in: Neurotherapeutics 2/2018

Open Access 01-04-2018 | Review

Non-Pharmacological Approaches for Migraine

Authors: Francesca Puledda, Kevin Shields

Published in: Neurotherapeutics | Issue 2/2018

Login to get access

Abstract

Migraine is one of the most common and debilitating neurological disorders. However, the efficacy of pharmacological therapies may have unsatisfactory efficacy and can be poorly tolerated. There is a strong need in clinical practice for alternative approaches for both acute and preventive treatment. Occasionally, this need might arise in the context of low-frequency migraneurs who are not keen to use medication or fear the potential side effects. At the opposite end of the spectrum, clinicians might be faced with patients who have proven refractory to numerous medications. These patients may benefit from invasive treatment strategies. In recent years, promising strategies for migraine therapy have emerged alongside a progressively better understanding of the complex pathophysiology underlying this disease. This review discusses the most recent and evidence-based advances in non-pharmacological therapeutic approaches for migraine, offering alternatives to drug treatment for both the commonly encountered episodic cases as well as the more complex migraine phenotypes, which are capable of challenging even the headache specialist.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stewart WF, Wood C, Reed ML, Roy J, Lipton RB. Cumulative lifetime migraine incidence in women and men. Cephalalgia : an international journal of headache. 2008;28(11):1170–8.CrossRefPubMed Stewart WF, Wood C, Reed ML, Roy J, Lipton RB. Cumulative lifetime migraine incidence in women and men. Cephalalgia : an international journal of headache. 2008;28(11):1170–8.CrossRefPubMed
2.
go back to reference Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015;386(9995):743–800.CrossRef Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015;386(9995):743–800.CrossRef
3.
go back to reference Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia : an international journal of headache. 2015;35(6):478–88.CrossRefPubMed Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia : an international journal of headache. 2015;35(6):478–88.CrossRefPubMed
4.
go back to reference Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. The Lancet Neurology. 2010;9(3):285–98.CrossRefPubMed Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. The Lancet Neurology. 2010;9(3):285–98.CrossRefPubMed
5.
go back to reference Wells RE, Bertisch SM, Buettner C, Phillips RS, McCarthy EP. Complementary and alternative medicine use among adults with migraines/severe headaches. Headache. 2011;51(7):1087–97.CrossRefPubMedPubMedCentral Wells RE, Bertisch SM, Buettner C, Phillips RS, McCarthy EP. Complementary and alternative medicine use among adults with migraines/severe headaches. Headache. 2011;51(7):1087–97.CrossRefPubMedPubMedCentral
6.
go back to reference Welch KM, Levine SR, D'Andrea G, Schultz LR, Helpern JA. Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology. 1989;39(4):538–41.CrossRefPubMed Welch KM, Levine SR, D'Andrea G, Schultz LR, Helpern JA. Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology. 1989;39(4):538–41.CrossRefPubMed
7.
go back to reference Barbiroli B, Montagna P, Cortelli P, Funicello R, Iotti S, Monari L, et al. Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology. 1992;42(6):1209.CrossRefPubMed Barbiroli B, Montagna P, Cortelli P, Funicello R, Iotti S, Monari L, et al. Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology. 1992;42(6):1209.CrossRefPubMed
8.
go back to reference Watanabe H, Kuwabara T, Ohkubo M, Tsuji S, Yuasa T. Elevation of cerebral lactate detected by localized 1H-magnetic resonance spectroscopy in migraine during the interictal period. Neurology. 1996;47(4):1093–5.CrossRefPubMed Watanabe H, Kuwabara T, Ohkubo M, Tsuji S, Yuasa T. Elevation of cerebral lactate detected by localized 1H-magnetic resonance spectroscopy in migraine during the interictal period. Neurology. 1996;47(4):1093–5.CrossRefPubMed
9.
go back to reference Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis A randomized controlled trial. Neurology. 1998;50(2):466–70.CrossRefPubMed Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis A randomized controlled trial. Neurology. 1998;50(2):466–70.CrossRefPubMed
10.
go back to reference MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. Journal of child neurology. 2008;23(11):1300–4.CrossRefPubMed MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. Journal of child neurology. 2008;23(11):1300–4.CrossRefPubMed
11.
go back to reference Athaillah YD, Saing JH, Saing HB, Lelo A. Riboflavin as migraine prophylaxis in adolescents. Paediatr Indones. 2012;52:132–7.CrossRef Athaillah YD, Saing JH, Saing HB, Lelo A. Riboflavin as migraine prophylaxis in adolescents. Paediatr Indones. 2012;52:132–7.CrossRef
12.
go back to reference Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44(9):885–90.CrossRefPubMed Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44(9):885–90.CrossRefPubMed
13.
go back to reference Gaul C, Diener HC, Danesch U. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain. 2015;16:516.CrossRefPubMed Gaul C, Diener HC, Danesch U. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain. 2015;16:516.CrossRefPubMed
14.
go back to reference Di Lorenzo C, Pierelli F, Coppola G, Grieco GS, Rengo C, Ciccolella M, et al. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology. 2009;72(18):1588–94.CrossRefPubMed Di Lorenzo C, Pierelli F, Coppola G, Grieco GS, Rengo C, Ciccolella M, et al. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology. 2009;72(18):1588–94.CrossRefPubMed
15.
go back to reference Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713–5.CrossRefPubMed Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713–5.CrossRefPubMed
16.
go back to reference Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia : an international journal of headache. 2011;31(8):897–905.CrossRef Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia : an international journal of headache. 2011;31(8):897–905.CrossRef
17.
go back to reference Welch KM, Ramadan NM. Mitochondria, magnesium and migraine. Journal of the neurological sciences. 1995;134(1–2):9–14.CrossRefPubMed Welch KM, Ramadan NM. Mitochondria, magnesium and migraine. Journal of the neurological sciences. 1995;134(1–2):9–14.CrossRefPubMed
18.
go back to reference Gallai V, Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G. Serum and salivary magnesium levels in migraine. Results in a group of juvenile patients. Headache. 1992;32(3):132–5.CrossRefPubMed Gallai V, Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G. Serum and salivary magnesium levels in migraine. Results in a group of juvenile patients. Headache. 1992;32(3):132–5.CrossRefPubMed
19.
go back to reference Gallai V, Sarchielli P, Morucci P, Abbritti G. Red blood cell magnesium levels in migraine patients. Cephalalgia : an international journal of headache. 1993;13(2):94–81; discussion 73.CrossRefPubMed Gallai V, Sarchielli P, Morucci P, Abbritti G. Red blood cell magnesium levels in migraine patients. Cephalalgia : an international journal of headache. 1993;13(2):94–81; discussion 73.CrossRefPubMed
20.
go back to reference Mauskop A, Altura BT, Altura BM. Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache. 2002;42(4):242–8.CrossRefPubMed Mauskop A, Altura BT, Altura BM. Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache. 2002;42(4):242–8.CrossRefPubMed
21.
22.
go back to reference Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 1991;31(5):298–301.CrossRefPubMed Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 1991;31(5):298–301.CrossRefPubMed
23.
go back to reference Taubert K. [Magnesium in migraine. Results of a multicenter pilot study]. Fortschritte der Medizin. 1994;112(24):328–30.PubMed Taubert K. [Magnesium in migraine. Results of a multicenter pilot study]. Fortschritte der Medizin. 1994;112(24):328–30.PubMed
24.
go back to reference von Luckner A, Riederer F. Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review. Headache. 2018;58(2):199–209.CrossRef von Luckner A, Riederer F. Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review. Headache. 2018;58(2):199–209.CrossRef
25.
go back to reference Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, et al. Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study. Cephalalgia : an international journal of headache. 1996;16(6):436–40.CrossRefPubMed Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, et al. Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study. Cephalalgia : an international journal of headache. 1996;16(6):436–40.CrossRefPubMed
26.
go back to reference Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia : an international journal of headache. 1996;16(4):257–63.CrossRef Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia : an international journal of headache. 1996;16(4):257–63.CrossRef
27.
go back to reference Koseoglu E, Talaslioglu A, Gonul AS, Kula M. The effects of magnesium prophylaxis in migraine without aura. Magnesium research. 2008;21(2):101–8.PubMed Koseoglu E, Talaslioglu A, Gonul AS, Kula M. The effects of magnesium prophylaxis in migraine without aura. Magnesium research. 2008;21(2):101–8.PubMed
28.
go back to reference Rajapakse T, Pringsheim T. Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use. Headache. 2016;56(4):808–16.CrossRefPubMed Rajapakse T, Pringsheim T. Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use. Headache. 2016;56(4):808–16.CrossRefPubMed
29.
go back to reference Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004;63(12):2240–4.CrossRefPubMed Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004;63(12):2240–4.CrossRefPubMed
30.
go back to reference Diener HC, Rahlfs VW, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. European neurology. 2004;51(2):89–97.CrossRefPubMed Diener HC, Rahlfs VW, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. European neurology. 2004;51(2):89–97.CrossRefPubMed
31.
go back to reference Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia : an international journal of headache. 2005;25(11):1031–41.CrossRef Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia : an international journal of headache. 2005;25(11):1031–41.CrossRef
32.
go back to reference Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia : an international journal of headache. 2002;22(7):523–32.CrossRefPubMed Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia : an international journal of headache. 2002;22(7):523–32.CrossRefPubMed
33.
go back to reference Goslin RE, Gray RN, McCrory DC, Penzien D, Rains J, Hasselblad V. AHRQ Technical Reviews. Behavioral and Physical Treatments for Migraine Headache. Rockville (MD): Agency for Health Care Policy and Research (US); 1999. Goslin RE, Gray RN, McCrory DC, Penzien D, Rains J, Hasselblad V. AHRQ Technical Reviews. Behavioral and Physical Treatments for Migraine Headache. Rockville (MD): Agency for Health Care Policy and Research (US); 1999.
34.
go back to reference Penzien DB, Irby MB, Smitherman TA, Rains JC, Houle TT. Well-Established and Empirically Supported Behavioral Treatments for Migraine. Current pain and headache reports. 2015;19(7):34.CrossRefPubMed Penzien DB, Irby MB, Smitherman TA, Rains JC, Houle TT. Well-Established and Empirically Supported Behavioral Treatments for Migraine. Current pain and headache reports. 2015;19(7):34.CrossRefPubMed
35.
go back to reference Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754–62.CrossRefPubMed Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754–62.CrossRefPubMed
36.
go back to reference Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ (Clinical research ed). 2010;341:c4871. Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ (Clinical research ed). 2010;341:c4871.
37.
go back to reference Powers SW, Kashikar-Zuck SM, Allen JR, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: A randomized clinical trial. Jama. 2013;310(24):2622–30.CrossRefPubMedPubMedCentral Powers SW, Kashikar-Zuck SM, Allen JR, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: A randomized clinical trial. Jama. 2013;310(24):2622–30.CrossRefPubMedPubMedCentral
38.
go back to reference Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass SJ, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache. 2002;42(6):483–90.CrossRefPubMed Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass SJ, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache. 2002;42(6):483–90.CrossRefPubMed
39.
go back to reference Rausa M, Palomba D, Cevoli S, Lazzerini L, Sancisi E, Cortelli P, et al. Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. J Headache Pain. 2016;17(1):87.CrossRefPubMedPubMedCentral Rausa M, Palomba D, Cevoli S, Lazzerini L, Sancisi E, Cortelli P, et al. Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. J Headache Pain. 2016;17(1):87.CrossRefPubMedPubMedCentral
40.
go back to reference Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Vertosick EA, et al. Acupuncture for the prevention of episodic migraine. The Cochrane database of systematic reviews. 2016(6):Cd001218. Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Vertosick EA, et al. Acupuncture for the prevention of episodic migraine. The Cochrane database of systematic reviews. 2016(6):Cd001218.
41.
go back to reference Zhao L, Chen J, Li Y, et al. The long-term effect of acupuncture for migraine prophylaxis: A randomized clinical trial. JAMA Internal Medicine. 2017. Zhao L, Chen J, Li Y, et al. The long-term effect of acupuncture for migraine prophylaxis: A randomized clinical trial. JAMA Internal Medicine. 2017.
42.
go back to reference Linde K, Streng A, Jurgens S, Hoppe A, Brinkhaus B, Witt C, et al. Acupuncture for patients with migraine: a randomized controlled trial. Jama. 2005;293(17):2118–25.CrossRefPubMed Linde K, Streng A, Jurgens S, Hoppe A, Brinkhaus B, Witt C, et al. Acupuncture for patients with migraine: a randomized controlled trial. Jama. 2005;293(17):2118–25.CrossRefPubMed
43.
go back to reference Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. The Lancet Neurology. 2006;5(4):310–6.CrossRefPubMed Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. The Lancet Neurology. 2006;5(4):310–6.CrossRefPubMed
44.
go back to reference Gérardy PY, Fabry D, Fumal A, Schoenen J. A pilot study on supra-orbital surface electrotherapy in migraine. Cephalalgia : an international journal of headache. 2009(29):134. Gérardy PY, Fabry D, Fumal A, Schoenen J. A pilot study on supra-orbital surface electrotherapy in migraine. Cephalalgia : an international journal of headache. 2009(29):134.
45.
go back to reference Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gerard P, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80(8):697–704.CrossRefPubMed Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gerard P, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80(8):697–704.CrossRefPubMed
46.
go back to reference Magis D, Sava S, d'Elia TS, Baschi R, Schoenen J. Safety and patients' satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly(R) device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013;14:95.CrossRefPubMedPubMedCentral Magis D, Sava S, d'Elia TS, Baschi R, Schoenen J. Safety and patients' satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly(R) device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013;14:95.CrossRefPubMedPubMedCentral
47.
go back to reference Liu Y, Dong Z, Wang R, Ao R, Han X, Tang W, et al. Migraine prevention using different frequencies of transcutaneous occipital nerve stimulation: A randomized controlled trial. The journal of pain : official journal of the American Pain Society. 2017. Liu Y, Dong Z, Wang R, Ao R, Han X, Tang W, et al. Migraine prevention using different frequencies of transcutaneous occipital nerve stimulation: A randomized controlled trial. The journal of pain : official journal of the American Pain Society. 2017.
48.
go back to reference Schoenen J, D'Ostilio K, Cosseddu A, Nonis R, Sava S, Magis D. Transcranial Direct Current Stimulation and Transcutaneous Occipital Nerve Stimulation in Chronic Migraine: A Pilot-Comparison of Therapeutic and Electrophysiological Effects. Neurology. 2016;86(16 Supplement P2.200). Schoenen J, D'Ostilio K, Cosseddu A, Nonis R, Sava S, Magis D. Transcranial Direct Current Stimulation and Transcutaneous Occipital Nerve Stimulation in Chronic Migraine: A Pilot-Comparison of Therapeutic and Electrophysiological Effects. Neurology. 2016;86(16 Supplement P2.200).
49.
go back to reference Sadler RM, Purdy RA, Rahey S. Vagal nerve stimulation aborts migraine in patient with intractable epilepsy. Cephalalgia : an international journal of headache. 2002;22(6):482–4.CrossRef Sadler RM, Purdy RA, Rahey S. Vagal nerve stimulation aborts migraine in patient with intractable epilepsy. Cephalalgia : an international journal of headache. 2002;22(6):482–4.CrossRef
50.
go back to reference Goadsby PJ, Grosberg BM, Mauskop A, Cady R, Simmons KA. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia : an international journal of headache. 2014;34(12):986–93.CrossRefPubMed Goadsby PJ, Grosberg BM, Mauskop A, Cady R, Simmons KA. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia : an international journal of headache. 2014;34(12):986–93.CrossRefPubMed
51.
go back to reference Barbanti P, Grazzi L, Egeo G, Padovan AM, Liebler E, Bussone G. Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study. J Headache Pain. 2015;16:61.CrossRefPubMedPubMedCentral Barbanti P, Grazzi L, Egeo G, Padovan AM, Liebler E, Bussone G. Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study. J Headache Pain. 2015;16:61.CrossRefPubMedPubMedCentral
52.
go back to reference Magis D, Gerard P, Schoenen J. Transcutaneous Vagus Nerve Stimulation (tVNS) for headache prophylaxis: initial experience. J Headache Pain. 2013;14(Suppl 1):198.CrossRef Magis D, Gerard P, Schoenen J. Transcutaneous Vagus Nerve Stimulation (tVNS) for headache prophylaxis: initial experience. J Headache Pain. 2013;14(Suppl 1):198.CrossRef
53.
go back to reference Grazzi L, Egeo G, Calhoun AH, McClure CK, Liebler E, Barbanti P. Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study. J Headache Pain. 2016;17(1). Grazzi L, Egeo G, Calhoun AH, McClure CK, Liebler E, Barbanti P. Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study. J Headache Pain. 2016;17(1).
54.
go back to reference Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S, et al. Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study. Neurology. 2016;87(5):529–38.CrossRefPubMedPubMedCentral Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S, et al. Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study. Neurology. 2016;87(5):529–38.CrossRefPubMedPubMedCentral
55.
go back to reference Straube A, Ellrich J, Eren O, Blum B, Ruscheweyh R. Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial. J Headache Pain. 2015;16:543.CrossRefPubMed Straube A, Ellrich J, Eren O, Blum B, Ruscheweyh R. Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial. J Headache Pain. 2015;16:543.CrossRefPubMed
56.
go back to reference Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain : a journal of neurology. 2016;139(Pt 7):2002–14.CrossRef Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain : a journal of neurology. 2016;139(Pt 7):2002–14.CrossRef
57.
go back to reference Clarke BM, Upton AR, Kamath MV, Al-Harbi T, Castellanos CM. Transcranial magnetic stimulation for migraine: clinical effects. J Headache Pain. 2006;7(5):341–6.CrossRefPubMedPubMedCentral Clarke BM, Upton AR, Kamath MV, Al-Harbi T, Castellanos CM. Transcranial magnetic stimulation for migraine: clinical effects. J Headache Pain. 2006;7(5):341–6.CrossRefPubMedPubMedCentral
58.
go back to reference Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. The Lancet Neurology. 2010;9(4):373–80.CrossRefPubMed Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. The Lancet Neurology. 2010;9(4):373–80.CrossRefPubMed
59.
go back to reference Bhola R, Kinsella E, Giffin N, Lipscombe S, Ahmed F, Weatherall M, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015;16:535.CrossRefPubMed Bhola R, Kinsella E, Giffin N, Lipscombe S, Ahmed F, Weatherall M, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015;16:535.CrossRefPubMed
60.
go back to reference Bruggenjurgen B, Baker T, Bhogal R, Ahmed F. Cost impact of a non-invasive, portable device for patient self-administration of chronic migraine in a UK National Health Service setting. SpringerPlus. 2016;5(1):1249.CrossRefPubMedPubMedCentral Bruggenjurgen B, Baker T, Bhogal R, Ahmed F. Cost impact of a non-invasive, portable device for patient self-administration of chronic migraine in a UK National Health Service setting. SpringerPlus. 2016;5(1):1249.CrossRefPubMedPubMedCentral
61.
go back to reference Antal A, Kriener N, Lang N, Boros K, Paulus W. Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine. Cephalalgia : an international journal of headache. 2011;31(7):820–8.CrossRef Antal A, Kriener N, Lang N, Boros K, Paulus W. Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine. Cephalalgia : an international journal of headache. 2011;31(7):820–8.CrossRef
62.
go back to reference Rocha S, Melo L, Boudoux C, Foerster A, Araujo D, Monte-Silva K. Transcranial direct current stimulation in the prophylactic treatment of migraine based on interictal visual cortex excitability abnormalities: A pilot randomized controlled trial. Journal of the neurological sciences. 2015;349(1–2):33–9.CrossRefPubMed Rocha S, Melo L, Boudoux C, Foerster A, Araujo D, Monte-Silva K. Transcranial direct current stimulation in the prophylactic treatment of migraine based on interictal visual cortex excitability abnormalities: A pilot randomized controlled trial. Journal of the neurological sciences. 2015;349(1–2):33–9.CrossRefPubMed
63.
go back to reference Auvichayapat P, Janyacharoen T, Rotenberg A, Tiamkao S, Krisanaprakornkit T, Sinawat S, et al. Migraine prophylaxis by anodal transcranial direct current stimulation, a randomized, placebo-controlled trial. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2012;95(8):1003–12.PubMed Auvichayapat P, Janyacharoen T, Rotenberg A, Tiamkao S, Krisanaprakornkit T, Sinawat S, et al. Migraine prophylaxis by anodal transcranial direct current stimulation, a randomized, placebo-controlled trial. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2012;95(8):1003–12.PubMed
64.
go back to reference Dasilva AF, Mendonca ME, Zaghi S, Lopes M, Dossantos MF, Spierings EL, et al. tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine. Headache. 2012;52(8):1283–95.CrossRefPubMedPubMedCentral Dasilva AF, Mendonca ME, Zaghi S, Lopes M, Dossantos MF, Spierings EL, et al. tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine. Headache. 2012;52(8):1283–95.CrossRefPubMedPubMedCentral
65.
go back to reference Vigano A, D'Elia TS, Sava SL, Auve M, De Pasqua V, Colosimo A, et al. Transcranial Direct Current Stimulation (tDCS) of the visual cortex: a proof-of-concept study based on interictal electrophysiological abnormalities in migraine. J Headache Pain. 2013;14:23.CrossRefPubMedPubMedCentral Vigano A, D'Elia TS, Sava SL, Auve M, De Pasqua V, Colosimo A, et al. Transcranial Direct Current Stimulation (tDCS) of the visual cortex: a proof-of-concept study based on interictal electrophysiological abnormalities in migraine. J Headache Pain. 2013;14:23.CrossRefPubMedPubMedCentral
66.
go back to reference Wang J, Dong WW, Zhang WH, Zheng J, Wang X. Electrical stimulation of cerebellar fastigial nucleus: mechanism of neuroprotection and prospects for clinical application against cerebral ischemia. CNS neuroscience & therapeutics. 2014;20(8):710–6.CrossRef Wang J, Dong WW, Zhang WH, Zheng J, Wang X. Electrical stimulation of cerebellar fastigial nucleus: mechanism of neuroprotection and prospects for clinical application against cerebral ischemia. CNS neuroscience & therapeutics. 2014;20(8):710–6.CrossRef
67.
go back to reference Juan Y, Shu O, Jinhe L, Na Y, Yushuang D, Weiwei D, et al. Migraine prevention with percutaneous mastoid electrical stimulator: A randomized double-blind controlled trial. Cephalalgia : an international journal of headache. 2016. Juan Y, Shu O, Jinhe L, Na Y, Yushuang D, Weiwei D, et al. Migraine prevention with percutaneous mastoid electrical stimulator: A randomized double-blind controlled trial. Cephalalgia : an international journal of headache. 2016.
68.
go back to reference Yarnitsky D, Volokh L, Ironi A, Weller B, Shor M, Shifrin A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017;88(13):1250–5.CrossRefPubMed Yarnitsky D, Volokh L, Ironi A, Weller B, Shor M, Shifrin A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017;88(13):1250–5.CrossRefPubMed
69.
go back to reference Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: current concepts and synthesis. Current pain and headache reports. 2003;7(5):371–6.CrossRefPubMed Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: current concepts and synthesis. Current pain and headache reports. 2003;7(5):371–6.CrossRefPubMed
70.
go back to reference Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain : a journal of neurology. 2002;125(Pt 7):1496–509.CrossRef Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain : a journal of neurology. 2002;125(Pt 7):1496–509.CrossRef
71.
go back to reference Lipton R, Goadsby PJ, Cady R, Aurora SK, Grosberg BM, Freitag F. PRISM study: occipital nerve stimulation for treatment-refractory migraine [abstract PO47]. Cephalalgia : an international journal of headache. 2009;29. Lipton R, Goadsby PJ, Cady R, Aurora SK, Grosberg BM, Freitag F. PRISM study: occipital nerve stimulation for treatment-refractory migraine [abstract PO47]. Cephalalgia : an international journal of headache. 2009;29.
72.
go back to reference Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia : an international journal of headache. 2011;31(3):271–85.CrossRef Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia : an international journal of headache. 2011;31(3):271–85.CrossRef
73.
go back to reference Silberstein SD, Dodick DW, Saper J, Huh B, Slavin KV, Sharan A, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia : an international journal of headache. 2012;32(16):1165–79.CrossRef Silberstein SD, Dodick DW, Saper J, Huh B, Slavin KV, Sharan A, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia : an international journal of headache. 2012;32(16):1165–79.CrossRef
74.
go back to reference Chen YF, Bramley G, Unwin G, Hanu-Cernat D, Dretzke J, Moore D, et al. Occipital Nerve Stimulation for Chronic Migraine—A Systematic Review and Meta-Analysis. PloS one. 2015;10(3). Chen YF, Bramley G, Unwin G, Hanu-Cernat D, Dretzke J, Moore D, et al. Occipital Nerve Stimulation for Chronic Migraine—A Systematic Review and Meta-Analysis. PloS one. 2015;10(3).
75.
go back to reference Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain : a journal of neurology. 1997;120 ( Pt 1):193–209.CrossRef Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain : a journal of neurology. 1997;120 ( Pt 1):193–209.CrossRef
76.
go back to reference Goadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. The New England journal of medicine. 2002;346(4):257–70.CrossRefPubMed Goadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. The New England journal of medicine. 2002;346(4):257–70.CrossRefPubMed
77.
go back to reference Maizels M, Geiger AM. Intranasal lidocaine for migraine: a randomized trial and open-label follow-up. Headache. 1999;39(8):543–51.CrossRefPubMed Maizels M, Geiger AM. Intranasal lidocaine for migraine: a randomized trial and open-label follow-up. Headache. 1999;39(8):543–51.CrossRefPubMed
78.
go back to reference Tepper SJ, Rezai A, Narouze S, Steiner C, Mohajer P, Ansarinia M. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache. 2009;49(7):983–9.CrossRefPubMed Tepper SJ, Rezai A, Narouze S, Steiner C, Mohajer P, Ansarinia M. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache. 2009;49(7):983–9.CrossRefPubMed
79.
go back to reference De Agostino R, Federspiel B, Cesnulis E, Sandor PS. High-cervical spinal cord stimulation for medically intractable chronic migraine. Neuromodulation : journal of the International Neuromodulation Society. 2015;18(4):289–96; discussion 96. De Agostino R, Federspiel B, Cesnulis E, Sandor PS. High-cervical spinal cord stimulation for medically intractable chronic migraine. Neuromodulation : journal of the International Neuromodulation Society. 2015;18(4):289–96; discussion 96.
80.
go back to reference Arcioni R, Palmisani S, Mercieri M, Vano V, Tigano S, Smith T, et al. Cervical 10 kHz spinal cord stimulation in the management of chronic, medically refractory migraine: A prospective, open-label, exploratory study. European journal of pain (London, England). 2016;20(1):70–8.CrossRef Arcioni R, Palmisani S, Mercieri M, Vano V, Tigano S, Smith T, et al. Cervical 10 kHz spinal cord stimulation in the management of chronic, medically refractory migraine: A prospective, open-label, exploratory study. European journal of pain (London, England). 2016;20(1):70–8.CrossRef
Metadata
Title
Non-Pharmacological Approaches for Migraine
Authors
Francesca Puledda
Kevin Shields
Publication date
01-04-2018
Publisher
Springer International Publishing
Published in
Neurotherapeutics / Issue 2/2018
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1007/s13311-018-0623-6

Other articles of this Issue 2/2018

Neurotherapeutics 2/2018 Go to the issue